ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.74
1.16%
US Tech 100
18,893.20
2.07%
S&P 500
5,531.27
1.39%
US Dollar vs CAD
1.36975
-0.14%
Bitcoin
59,709.10
1.70%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Twist Bioscience Corporation (TWST)

  7. Twist Bioscience Corporation (TWST) News

TWST

Twist Bioscience (TWST)

Twist Bioscience Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TWST
DateTimeSourceHeadlineSymbolCompany
08/08/20247:00AMBusiness WireTwist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kbNASDAQ:TWSTTwist Bioscience Corporation
08/07/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/07/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/07/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/07/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/07/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/06/20249:13AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/06/20247:00AMBusiness WireTwist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:TWSTTwist Bioscience Corporation
08/05/20242:47PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/05/20242:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/05/20242:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/05/20242:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/05/20242:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/05/20242:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
08/05/20247:00AMBusiness WireTwist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for BiocatalysisNASDAQ:TWSTTwist Bioscience Corporation
08/02/20243:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TWSTTwist Bioscience Corporation
08/02/20246:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TWSTTwist Bioscience Corporation
08/02/20246:30AMBusiness WireTwist Bioscience Reports Fiscal Third Quarter 2024 Financial ResultsNASDAQ:TWSTTwist Bioscience Corporation
08/01/20249:39AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
07/25/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
07/23/20242:17PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
07/18/20247:00AMBusiness WireTwist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody LibrariesNASDAQ:TWSTTwist Bioscience Corporation
07/11/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
07/11/20247:00AMBusiness WireTwist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024NASDAQ:TWSTTwist Bioscience Corporation
07/10/20247:00AMBusiness WireTwist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express AntibodiesNASDAQ:TWSTTwist Bioscience Corporation
07/09/20242:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
07/09/20247:00AMBusiness WireTwist Bioscience Launches Synthetic RNA Control for H5N1 Influenza ANASDAQ:TWSTTwist Bioscience Corporation
06/18/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
06/14/20242:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TWSTTwist Bioscience Corporation
06/10/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TWSTTwist Bioscience Corporation
 Showing the most relevant articles for your search:NASDAQ:TWST

Your Recent History

USOTC
SPZI
Spooz (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
ASTA
Astra Veda (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
CEOS
CeCors (PK)
USOTC
RXMD
Progressive Care (QB)
USOTC
AFFU
Affluence (PK)
USOTC
TXTM
ProText Mobility (PK)
USOTC
AXXA
Exxe (PK)
NYSE
LUMN
Lumen Technologies
USOTC
NSAV
Net Savings Link (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
AHRO
Authentic (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved